Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 03, 2021

SELL
$225.08 - $271.69 $1.22 Million - $1.47 Million
-5,417 Closed
0 $0
Q1 2021

May 20, 2021

BUY
$212.38 - $245.9 $60,315 - $69,835
284 Added 5.53%
5,417 $1.22 Million
Q4 2020

Mar 09, 2021

BUY
$212.5 - $245.46 $15,725 - $18,164
74 Added 1.46%
5,133 $1.14 Million
Q3 2020

Nov 19, 2020

SELL
$177.16 - $215.33 $457,427 - $555,982
-2,582 Reduced 33.79%
5,059 $1.09 Million
Q2 2020

Aug 19, 2020

BUY
$128.7 - $176.83 $20,720 - $28,469
161 Added 2.15%
7,641 $1.35 Million
Q1 2020

May 19, 2020

BUY
$121.39 - $169.05 $856,770 - $1.19 Million
7,058 Added 1672.51%
7,480 $1.04 Million
Q4 2019

May 19, 2020

BUY
$133.47 - $153.48 $56,324 - $64,768
422 New
422 $26,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Tru Independence LLC Portfolio

Follow Tru Independence LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tru Independence LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tru Independence LLC with notifications on news.